Altabancorp™ Reports Fourth Quarter and Year-End 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Alterola Biotech, Inc. (ALTA) Tops Q4 EPS by 5c
January 27, 2021 5:22 PM ESTAlterola Biotech, Inc. (NASDAQ: ALTA) reported Q4 EPS of $0.58, $0.05 better than the analyst estimate of $0.53.
2020 was a challenging year for our organization, our associates, and our clients as we collectively managed the negative effects of the COVID-19 pandemic, said Len Williams, President and Chief Executive Officer of AltabancorpTM. Many of our associates have been working from home since March 2020. Most of our branch lobbies have been available by... More
